MerLion Pharma (Germany)
Novel antibiotic development
company in Berlin, Germany
Company details
- Sector
- Healthcare & Pharma
- Address
- Berlin, Germany
- Website
- merlionpharma.com
Services
- Finafloxacin development — Research, clinical trials, and regulatory approval of a next‑generation fluoroquinolone antibiotic
- Xtoro™ — FDA‑ and Health Canada‑approved ear infection treatment
- Biothreat countermeasure development — Program with UK Defence Science and Technology Laboratory for bioweapon pathogens
Industries served
pharmaceuticals
Highlights
- Xtoro™ approved by FDA and Health Canada
- Phase III trials completed for Xtoro™
- Phase II trials for cUTI
- Partnership with UK Dstl and US DTRA
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- merlionpharma.com
- Registrar
- INWX GmbH
- Registered
- 15 Nov 2001
- Expires
- 15 Nov 2026
- Record updated
- 19 Nov 2025
- Name servers
- ns.inwx.de, ns2.inwx.de, ns3.inwx.eu
- DNSSEC
- Signed